1 |
BREGNI G, BECK B. Toward targeted therapies in oesophageal cancers: an overview [J]. Cancers (Basel), 2022, 14(6): 1522.
|
2 |
PARKIN D M. Global cancer statistics in the year 2000 [J]. Lancet Oncol, 2001, 2(9): 533-43.
|
3 |
TRAN G D, SUN X D, ABNET C C, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China [J]. Int J Cancer, 2005, 113(3): 456-463.
|
4 |
SONG Y, LI L, OU Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer [J]. Nature, 2014, 509(7498): 91-95.
|
5 |
KANO M, SEKI N, KIKKAWA N, et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma [J]. Int J Cancer, 2010, 127(12): 2804-2814.
|
6 |
YANG L, ZHOU W, LIN H. Posttranslational modifications of smurfs: emerging regulation in cancer [J]. Front Oncol, 2020, 10:610663.
|
7 |
ZHANG Y, DING H, WANG X, et al. MK2 promotes Tfcp2l1 degradation via β-TrCP ubiquitin ligase to regulate mouse embryonic stem cell self-renewal [J]. Cell Rep, 2021, 37(5): 109949.
|
8 |
XIE H, HE Y, WU Y, et al. Silencing of UBE2D1 inhibited cell migration in gastric cancer, decreasing ubiquitination of SMAD4 [J]. Infect Agent Cancer, 2021, 16(1): 63.
|
9 |
WANG K, LIU X. Determining the effects of neddylation on cullin-RING ligase-dependent protein ubiquitination [J]. Curr Protoc, 2022, 2(3): e401.
|
10 |
KOGANTI P, LEVY-COHEN G, BLANK M. Smurfs in protein homeostasis, signaling, and cancer [J]. Front Oncol, 2018, 8: 295.
|
11 |
刘朦迪, 潘漪莲, 朱晓娜, 等. FBXO22调控凋亡诱导因子的分子机制及其在肿瘤细胞凋亡中的作用 [J]. 上海交通大学学报(医学版), 2021, 41(4): 427-33.
|
|
LIU M D, PAN Y L, ZHU X N, et al. FBXO22 regulates the molecular mechanism of apoptosis inducers and its role in tumor cell apoptosis[J]. J Shanghai Jiao Tong Univ (Med Sci), 2021, 41(04): 427-433.
|
12 |
KOMANDER D, RAPE M. The ubiquitin code [J]. Annu Rev Biochem, 2012, 81: 203-229.
|
13 |
GUO X, WANG X F. Signaling cross-talk between TGF-β/BMP and other pathways [J]. Cell Res, 2009, 19(1): 71-88.
|
14 |
DEMPKE W C M, FENCHEL K, UCIECHOWSKI P, et al. Targeting developmental pathways: the achilles heel of cancer? [J]. Oncology, 2017, 93(4): 213-223.
|
15 |
HAUPT Y, MAYA R, KAZAZ A, et al. Mdm2 promotes the rapid degradation of p53 [J]. Nature, 1997, 387(6630): 296-299.
|
16 |
KWEI K A, SHAIN A H, BAIR R, et al. SMURF1 amplification promotes invasiveness in pancreatic cancer [J]. PLoS One, 2011, 6(8): e23924.
|
17 |
FUKUCHI M, FUKAI Y, MASUDA N, et al. High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma [J]. Cancer Res, 2002, 62(24): 7162-7165.
|
18 |
ZHONG J, OGURA K, WANG Z, et al. Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis [J]. Discov Med, 2013, 15(80): 7-15.
|
19 |
ORIAN A, GONEN H, BERCOVICH B, et al. SCF(β)(-TrCP) ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase [J]. EMBO J, 2000, 19(11): 2580-2591.
|
20 |
ZHANG B, ZHANG Z, LI L, et al. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling [J]. Nat Commun, 2018, 9(1): 1423.
|
21 |
ZHOU C, BI F, YUAN J, et al. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6 [J]. J Exp Clin Cancer Res, 2018, 37(1): 290.
|
22 |
JACOBSEN A, BOSCH L J W, MARTENS-DE KEMP S R, et al. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer [J]. Sci Rep, 2018, 8(1): 7522.
|
23 |
METZGER R, HEUKAMP L, DREBBER U, et al. CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer [J]. Pharmacogenomics, 2010, 11(8): 1105-1113.
|